# Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System

> **NCT07745244** · NA · RECRUITING · sponsor: **SiBionics, Co, Ltd** · enrollment: 36 (estimated)

## Conditions studied

- type1diabetes
- CGM
- T1D

## Interventions

- **DEVICE:** GS3 CGM

## Key facts

- **NCT ID:** NCT07745244
- **Lead sponsor:** SiBionics, Co, Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07745244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07745244, "Evaluation of the Accuracy and Safety of a Continuous Glucose Monitoring System". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07745244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*